Jane Street
EDIT icon

Jane Street’s Editas Medicine EDIT Stock Holding History

Jane Street’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$218K Buy
67,400
+26,300
+64% +$76.9K ﹤0.01% 9933
2026
Q1 		$102K Buy
+41,100
New +$87K ﹤0.01% 10647
2024
Q1 		– Sell
-61,100
Closed -$619K – 9398
2023
Q4 		$619K Buy
61,100
+28,000
+85% +$246K ﹤0.01% 6395
2023
Q3 		$258K Sell
33,100
-2,200
-6% -$18.9K ﹤0.01% 7285
2023
Q2 		$291K Buy
35,300
+22,800
+182% +$199K ﹤0.01% 7174
2023
Q1 		$90.6K Sell
12,500
-45,900
-79% -$408K ﹤0.01% 8268
2022
Q4 		$518K Sell
58,400
-34,100
-37% -$374K ﹤0.01% 6071
2022
Q3 		$1.13M Buy
92,500
+33,600
+57% +$524K ﹤0.01% 5191
2022
Q2 		$697K Sell
58,900
-46,600
-44% -$624K ﹤0.01% 6128
2022
Q1 		$2.01M Sell
105,500
-123,100
-54% -$2.29M ﹤0.01% 4744
2021
Q4 		$6.07M Sell
228,600
-271,700
-54% -$9.35M ﹤0.01% 2557
2021
Q3 		$20.6M Buy
500,300
+213,700
+75% +$11.7M 0.01% 1122
2021
Q2 		$16.2M Sell
286,600
-11,500
-4% -$425K 0.01% 1260
2021
Q1 		$12.5M Buy
298,100
+72,000
+32% +$4.1M 0.01% 1344
2020
Q4 		$15.9M Buy
226,100
+167,100
+283% +$6.86M 0.01% 1037
2020
Q3 		$1.66M Buy
59,000
+18,100
+44% +$590K ﹤0.01% 3322
2020
Q2 		$1.21M Buy
+40,900
New +$1.07M ﹤0.01% 3790
2020
Q1 		– Sell
-27,300
Closed -$808K – 5427
2019
Q4 		$808K Buy
+27,300
New +$682K ﹤0.01% 3066
2018
Q2 		– Sell
-17,700
Closed -$587K – 5080
2018
Q1 		$587K Buy
+17,700
New +$631K ﹤0.01% 3302
2017
Q4 		– Sell
-17,900
Closed -$430K – 4681
2017
Q3 		$430K Buy
+17,900
New +$341K ﹤0.01% 3284

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Jane Street's EDIT Position: Q2 2026 in Review

Jane Street reduced its Editas Medicine (EDIT) stake by 13% in Q2 2026, selling an estimated $49.9K and leaving 115,578 shares worth $374K. The position accounts for ﹤0.01% of the portfolio, ranked #8682.

Jane Street first reported a position in EDIT in Q3 2017 and has held it in 30 quarters since. The position peaked at $10.5M in Q1 2021. 216 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Jane Street held 115,578 shares of Editas Medicine worth $374K as of Q2 2026.
  • Jane Street sold 17,083 Editas Medicine shares in Q2 2026, an estimated $49.9K.
  • Editas Medicine made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #8682 holding.
  • Jane Street first reported a position in Editas Medicine in Q3 2017 and has held it in 30 quarters since.
  • Jane Street's Editas Medicine position peaked at $10.5M in Q1 2021.
  • 216 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.